FDA Drug Recalls

Recalls / Class III

Class IIID-0322-2020

Product

Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603

Affected lot / code info
Lot #: TXWW, TXTW, Exp. date Dec 2019; AXPS, AXLS, AXBS AXNS, Exp. date Oct 2021; AXZL, AXAL, AXTL, AXWL, Exp. date Jun 2021.

Why it was recalled

Subpotent Drug

Recalling firm

Firm
Sato Pharmaceutical Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
20695 S Western Ave Ste 240, N/A, Torrance, California 90501-1834

Distribution

Quantity
21,864 units
Distribution pattern
Nationwide within the United States, Guam and Saipan

Timeline

Recall initiated
2019-10-01
FDA classified
2019-11-13
Posted by FDA
2019-11-20
Terminated
2020-08-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0322-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls